Qube Research & Technologies Ltd - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,412,020
+113.8%
40,254
+157.3%
0.01%
+50.0%
Q2 2023$1,127,932
+192.2%
15,644
+198.1%
0.00%
+100.0%
Q1 2023$386,043
+53.4%
5,248
+39.3%
0.00%
+100.0%
Q4 2022$251,636
-63.6%
3,767
-53.0%
0.00%
-75.0%
Q3 2022$691,000
-62.9%
8,022
-61.6%
0.00%
-71.4%
Q2 2022$1,862,000
+121.9%
20,871
+179.8%
0.01%
+100.0%
Q1 2022$839,000
-51.5%
7,459
-51.8%
0.01%
-72.0%
Q2 2020$1,730,00015,4680.02%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders